RespirAI Medical

Wearable Monitoring System for Home-based Disease Management

Health Tech & Life Sciences
Private

Company Overview

Snapshot

Founded in October 2020 by Nimrod Bin-Nun and Assaf Gur, RespirAI Medical operates with 1–10 employees. The company has raised $1M across five funding rounds and has received funding from eHealth Ventures. In January 2025, RespirAI Medical secured a grant from the BIRD Foundation.

Business overview

RespirAI Medical is developing a wearable disease-management platform for home monitoring, focusing on improving patient quality of life and reducing healthcare costs. Its core technology, based on research from the University of Nebraska at Omaha, uses passive sensing to capture medical-grade physiological data. This data is then synced to the cloud for analysis with advanced algorithms and artificial intelligence, enabling early detection of health changes before symptoms manifest. The company serves patients, healthcare providers, and families within the Health Tech & Life Sciences sector, specifically in Digital Healthcare and Patient Remote Monitoring.

Strategic signal

In August 2024, news highlighted RespirAI Medical's potential to predict COPD flare-ups using smartwatch technology. This signals a significant advancement in proactive disease management, demonstrating the company's capability to leverage wearable devices and AI for early intervention, which could lead to improved patient outcomes and reduced healthcare burdens.

Company Intelligence Q&A

When was RespirAI Medical founded and by whom?
RespirAI Medical was founded in October 2020 by co-founders Nimrod Bin-Nun and Assaf Gur.
What is RespirAI Medical's primary focus?
RespirAI Medical focuses on developing a wearable disease-management platform for home monitoring, aiming to detect changes in patient health at an early stage.
What significant grant did RespirAI Medical receive?
In January 2025, RespirAI Medical secured a grant from the BIRD Foundation, which was highlighted in news reports from Calcalistech.com.
Which investor participated in RespirAI Medical's funding rounds?
eHealth Ventures participated in RespirAI Medical's funding rounds in January 2021 and January 2022.
What was a key development reported in August 2024 regarding RespirAI Medical's technology?
In August 2024, it was reported that RespirAI Medical's technology could potentially predict COPD flare-ups via smartwatch, indicating advancements in proactive health monitoring.

External links